Kissei Pharmaceutical (OTCMKTS:KSPHF – Get Free Report) is expected to issue its resultson Friday, July 31st. Analysts expect Kissei Pharmaceutical to announce earnings of $0.3941 per share and revenue of $136.4240 million for the quarter.
Kissei Pharmaceutical Stock Performance
Shares of KSPHF stock opened at $25.77 on Wednesday. Kissei Pharmaceutical has a 1 year low of $23.23 and a 1 year high of $31.90. The firm’s 50 day moving average is $25.77 and its 200-day moving average is $26.16.
Kissei Pharmaceutical Company Profile
Kissei Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company that specializes in the research, development and manufacture of prescription drugs across a range of therapeutic areas. Founded in 1946 and incorporated in 1950, Kissei has built a reputation for its work in urology, nephrology, endocrinology, respiratory medicine and oncology. Through its dedicated in-house research centers, the company advances novel small molecules and biologic candidates from early discovery through clinical development.
The company’s product portfolio includes treatments for benign prostatic hyperplasia, chronic kidney disease, type 2 diabetes and various forms of cancer.
Featured Stories
- Five stocks we like better than Kissei Pharmaceutical
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
